This approach is to bring the Federation in line with one of the standards published by the International Academy of CPD Accreditation (IACPDA) in 2020 and is also in line with other accrediting bodies in North America and Europe. For clarity, there is no change in our policy relating to any other CPD providers that may have sponsorship from a pharmaceutical company, device company or other commercial organisation providing healthcare products (or more than one of these organisations), which will still be accepted for review.
Any applications that have already been submitted will continue to be processed and reviewed, however, from 12 September 2022, no new applications will be accepted. Full details of the new policy will be published on our website.